|
Services
1-15-2020 Services offered
· Multidisciplinary, standard and personalized care, published innovations in safe chemotherapy applied for 30 years (see foot note)
· Potentiate Coordination of care: chemotherapy; radiation therapy; immunotherapy; interventional radiology and surgery
The goal is stage IV complete remissions; step wise compartments are cleared. New Radiotherapy and immunotherapy.
Standard and complex high risk and resistant patients: expanded eligibility; treatments; safety and personalized treatments
· Education individual, group conferences, lectures,
· Consults: Primary, and cecond opinions, Referral assistance, research triage, lLab data - third generation tumor testing yield extra treatments designed to avoid false positive and false negative. Safety considered New prognostic insights see SIGO avoid false pessimism
|
We activate otherwise abandoned drugs Novel regimens add years of life
|
·
Supplementary therapy Downsizing tumors before and prevention of recurrence after surgery
o Neo adjuvant and adjuvant therapy, extras, supplements, & re conditioning
· Evaluation: extra monitoring of therapy for benefit, imminent failure and safety
· Family history: genetics, tests, education, referral, prevention choices
· Support services: financial assistance; education; lifestyle; alternative medicine and education
· Standard or Concierge E-conferences/Teleconferences/phone consultations
· Consults and follow up
|
E-conferences/Teleconferences/phone consultations
|
|
· National & International consults management coordinate care follow up
· Tumor testing primary, second opinions, added tests, personalized
o Tested safety and resistance solutions
· Nutrition correction, lifestyle Weight loss: prevent and correct
· Fitness, lifestyle and diet individualized
· Pain management
· Choice, evaluation, management of ports and special safer stents
· Hospital options: triage - referral choices
· Consultation drug development industry and research participation
Ovary, Gastric, Breast immunotherapy see progress report
· Research programmatic, adapted to individual care, personalized testing
o Immunotherapy, drug resistance clinical solutions second chance to work
· The above produced 250+ publications and reports, six already archived standard of care status
New developments are even better longer survival, complete responses, safer and cDNA biochemical remissions
|
